Eurand N.V. has reached
an agreement with Nycomed to sell and distribute Zenpep in Russia and the Commonwealth of Independent
States as well as Georgia
and Mongolia.
Deal terms were not disclosed.
Zenpep is a pancreatic enzyme that has been approved by the
U.S. Food and Drug Administration and treats pancreatic insufficiency in
patients with cystic fibrosis or conditions like chronic pancreatitis and
pancreatic cancer.
Eurand, which is based in Amsterdam,
markets Zenpep in the United
States.
Nycomed is a privately owned Swiss pharmaceutical company.